Evidence map›Paper›PMID 37762928›Full record

ArticleJournal of clinical medicine2023

Association between Major Adverse Cardiovascular Events and the Liver Fibrosis Score in Patients with and without Coronary Artery Disease: From the FU-CCTA Registry.

Yusuke Ajimu, Yuhei Shiga, Tetsuo Hirata, Kohei Tashiro, Sara Higashi, Yuto Kawahira, Yasunori Suematsu, Yuta Kato, Takashi Kuwano, Makoto Sugihara and 1 more

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.9field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Yusuke AjimuDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Yuhei ShigaDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Tetsuo HirataDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.ORCID 0000-0001-9671-2333
Kohei TashiroDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Sara HigashiDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Yuto KawahiraDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Yasunori SuematsuDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.ORCID 0000-0001-7966-5977
Yuta KatoDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Takashi KuwanoDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Makoto SugiharaDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Shin-Ichiro MiuraDepartment of Cardiology, Fukuoka University School of Medicine, Fukuoka 814-0133, Japan.
Fukuoka University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The liver fibrosis score reflects the degree of hepatic scarring and has been reported to be associated with cardiovascular disease. Using a coronary artery computed tomography angiography registry at the Fukuoka University Hospital (FU-CCTA registry), we investigated the association between major adverse cardiovascular events (MACEs) and the liver fibrosis score (fibrosis-4 index (FIB-4I)) in 612 patients who underwent CCTA to screen for coronary artery disease and performed a prognosis survey for up to 5 years. The primary endpoint was MACEs (all-cause mortality, acute myocardial infarction, ischemic stroke, coronary revascularization). FIB-4I in all patients and in patients with hypertension (HTN) was significantly higher in the MACE group than in the non-MACE group. The event-free survival rate of MACEs targeting only patients with HTN was significantly lower in patients with a high risk of liver fibrosis (FIB-4I values of 2.67 or higher) than in those with a low or intermediate risk (less than 2.67). However, no significant difference was observed in all patients or in patients without HTN. Finally, FIB-4I and body mass index were independent factors associated with MACEs in patients with HTN. In conclusion, the liver fibrosis score may be an independent predictor of MACEs in hypertensive patients undergoing CCTA.

Indexed as

coronary artery computed tomography angiographyhypertensionliver fibrosis scoremajor adverse cardiovascular events

Identifiers

PMID37762928
PMCPMC10532007
OpenAlexW4386837628

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.